KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to -$3.3 billion.

  • AbbVie's Cash from Investing Activities rose 6046.51% to -$3.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.1 billion, marking a year-over-year increase of 6427.63%. This contributed to the annual value of -$20.8 billion for FY2024, which is 93633.65% down from last year.
  • As of Q3 2025, AbbVie's Cash from Investing Activities stood at -$3.3 billion, which was up 6046.51% from -$1.2 billion recorded in Q2 2025.
  • In the past 5 years, AbbVie's Cash from Investing Activities registered a high of $1.3 billion during Q3 2022, and its lowest value of -$9.6 billion during Q1 2024.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$735.0 million (2025), whereas its average is -$1.6 billion.
  • Per our database at Business Quant, AbbVie's Cash from Investing Activities soared by 30910.57% in 2022 and then plummeted by 213739.84% in 2024.
  • Over the past 5 years, AbbVie's Cash from Investing Activities (Quarter) stood at -$1.1 billion in 2021, then skyrocketed by 60.87% to -$448.0 million in 2022, then plummeted by 78.57% to -$800.0 million in 2023, then crashed by 134.25% to -$1.9 billion in 2024, then crashed by 74.17% to -$3.3 billion in 2025.
  • Its Cash from Investing Activities stands at -$3.3 billion for Q3 2025, versus -$1.2 billion for Q2 2025 and -$735.0 million for Q1 2025.